Curisfera Newsroom
AV22 is not a universal antiviral yet—and that distinction matters
A molecule from researchers in Turin and Pisa appears active against influenza, coronaviruses and RSV in vitro, but laboratory breadth is only the first hurdle.
A molecule from researchers in Turin and Pisa appears active against influenza, coronaviruses and RSV in vitro, but laboratory breadth is only the first hurdle.